Retatrutide is one of the larger and more complex peptides in common laboratory use, which makes documentation matter more than usual. This guide covers what the compound is at a structural level and how to read its paperwork. It describes analytical checks only: Nordapep supplies retatrutide for in vitro laboratory research, not for use in people or animals.
The molecule in brief
Retatrutide, also catalogued as LY3437943, is a synthetic peptide of 39 amino acids. It is described in the literature as an agonist at three receptors: GIP, GLP-1 and glucagon. Its sequence includes non-natural residues and a fatty diacid side chain attached through a linker, a design feature shared with several long-acting incretin analogues.
That side chain is why its molecular weight sits well above what the amino acid count alone would suggest, at roughly 4.73 kDa. A long, lipidated peptide is harder to synthesise cleanly than a short one, so the gap between a careful batch and a careless one tends to be wider.
What the CoA should carry
For a compound this size, purity alone is not enough. A usable certificate shows:
- Identity by mass spectrometry, with an observed mass that agrees with the expected value of about 4731 Da. For a peptide this large the spectrum usually shows several charge states rather than a single peak.
- Purity by RP-HPLC, as a percentage by peak area, with the chromatogram included rather than just the number.
- The batch or lot number, matching the one printed on the vial or pen.
- The name of the laboratory that ran the analysis and the date it was run.
- The quantity per vial, and how it was determined.
Why identity matters more here
A purity figure only says how much of the sample is one thing. It does not say what that thing is. With incretin-type peptides there are several related compounds of similar size on the market, and a chromatogram alone cannot tell them apart. Mass spectrometry can: semaglutide, tirzepatide and retatrutide all have clearly different masses. If a certificate for retatrutide shows no mass data, the central question is still open.
Vials and pens
Lyophilised vials and pre-filled pens hold the same compound in different states. A vial contains dry material that is stable for longer and is reconstituted in the lab, so the working concentration is yours to set. A pen contains the peptide already in solution at a fixed concentration, which removes a preparation step but makes storage temperature and the stated expiry more important. In both cases the batch reference on the unit should lead to its own certificate.
Storage as general practice
Follow the storage statement on the batch label first. As a general rule, lyophilised peptide keeps best cold, dry and away from light, and material in solution has a much shorter working life than the dry powder. Lipidated peptides can also stick to some plastics at low concentration, so record the labware you use if your results depend on accurate concentration.